TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
CGEN

Compugen

Healthcare · Biotechnology

2.30$ -2.1% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement CGEN
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% – 100.0% – 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
27.0% 17.6% 31.3% – 5.8% – 3.0% 11.3% 13.0% 6.0% 28.5% 12.7%
73.0% 82.4% 68.7% – 94.2% – 97.0% 88.7% 87.0% 94.0% 71.5% 87.3%
121.9% 229.0% 3,447.9% – 170.3% – 1,138.0% 478.2% 408.6% 103.0% 89.0% 31.3%
44.1% 64.8% 1,032.2% – 45.2% – 490.3% 181.0% 137.6% 29.1% 33.9% 12.2%
172.7% 307.9% 4,644.9% – 224.7% – 1,671.8% 673.2% 558.7% 132.8% 125.0% 44.2%
-99.8% -225.5% -4,576.3% – -130.5% – -1,574.8% -584.6% -471.7% -38.8% -53.4% 43.1%
2.7% 8.1% 99.0% – 3.5% – 86.2% 14.5% 0.4% 0.1% 0.1% –
-86.8% -213.1% -4,422.2% – -127.0% – -1,484.9% -570.1% -448.5% -29.2% -34.8% 48.6%
2.9% 4.2% 2.8% – -7.1% – -121.9% -22.2% 0.8% 26.8% 16.2% 0.1%
-89.7% -217.3% -4,425.0% – -127.0% – -1,363.0% -547.9% -449.3% -56.1% -51.1% 48.6%
-94.4% -213.6% -4,367.8% – -122.7% – -1,539.1% -576.9% -465.2% -27.7% -33.0% 49.3%

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?